Go Pro
TSE:WEED

Canopy Growth Q3 2026 Earnings Report

Canopy Growth logo
C$1.31 -0.03 (-2.24%)
As of 07/20/2026 04:00 PM Eastern

Canopy Growth EPS Results

Actual EPS
-C$0.18
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Canopy Growth Revenue Results

Actual Revenue
$74.54 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Canopy Growth Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Canopy Growth Earnings Headlines

Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
Canopy Growth 4Q Loss Narrows, Revenue Rises
See More Canopy Growth Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Canopy Growth? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Canopy Growth and other key companies, straight to your email.

About Canopy Growth

Canopy Growth (TSE:WEED)oration, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

View Canopy Growth Profile